Fighting Back Against COVID-Vaccine Injury
Can some of the injuries inflicted by the COVID vaccines be reversed? Let’s take stock of which treatments are most promising, and get started with them.
Disclaimer
None of the substances mentioned below can be expected to accomplish a full reversal of vulnerability, risks and in some cases outright injury inflicted by the COVID vaccines, but one or more may possibly be effective enough for some people. As always, consult your local healthcare provider for your optimal individualized plan.
In the past I have referred to the post-vaccine recovery treatments recommended by Dr. Pierre Kory and Dr. Paul Marik. [1] However, I think there may be some more promising treatments, which I will discuss below.
Prevention is a lot easier than cure. This is why I usually focus my writing on prevention of harm, rather than trying to reverse it.
The COVID vaccines are so hazardous that, while maintaining a full-time medical practice (in a partly unrelated field, naturopathic oncology), I took time to write a book on the hazards of the COVID vaccines, in which I cited over 300 studies showing that these products were neither safe nor effective, the title of the book. [2] Those vaccines absolutely must be avoided at all costs, by all people of all age groups and occupations, without exception.
Nevertheless, let’s go after the spike protein as best we can, if you have already been injected.
The spike protein is the product manufactured by the hijacking of genetic machinery by mRNA COVID vaccines. These newly produced proteins are then taken throughout the body by circulating blood and lymph. Spike proteins have notoriously damaging effects on multiple bodily organs. I have written extensively in my book Neither Safe Nor Effective and my Substack articles on these mechanisms of injury. References on these premises of widespread pharmacokinetics and harmful effects on individuals around the world are now in the thousands, and these premises are now understood and accepted as true by increasingly large populations.
So how shall we reverse the effects of the spike proteins?
Ivermectin
Ivermectin has shown the greatest number of distinct effects against spike proteins of any substance I know. Of all substances, I think it offers the best help to the vaccine-injured, as well as to the unvaccinated who suspect that they have been exposed to spike proteins.
Ivermectin is produced from cultures of the bacteria Streptomyces avermitilis. You may know of ivermectin as having earned its developers Satoshi Omura and William Campbell the Nobel Prize in Physiology or Medicine in 2015, for its tremendous effect against river blindness and filariasis diseases in tropical regions. Its very broad range of anti-microbial activity has shown effects against diseases caused by roundworms, mites, lice and ticks as well and many viruses. [3] For this reason, ivermectin has been listed for many years in the World Health Organization’s List of Essential Medicines. [4] The reader may have also heard biased pronouncements of “horse paste” by journalists employed by media funded by competitive commercial interests against ivermectin.
Ivermectin has several mechanisms against spike protein.
One of its most impressive effects is that it binds the protein Importin alpha / Beta-1, which would allow passage of coronavirus carrying spike protein into the nucleus of human cells. [5] [6] [7] Ivermectin not only binds this Importin α / β-1 protein, but also destabilizes and inhibits it. This is one of the ways that ivermectin has been so effective against COVID-19 disease, over 95 studies to date in 27 countries. [8]
Ivermectin has been shown to block spike protein’s clumping effect (called hemagglutination, which can lead to clotting) on red blood cells when ivermectin was dosed either before or after exposure to spike protein. [9] Ivermectin accomplishes this anti-clumping effect by binding tightly to spike protein. [10] [11] Thus hemagglutination is prevented. This effect against red blood cell clumping is an extremely important action against clotting, which is one of the main means of harm caused by the COVID vaccines. Another mechanism of ivermectin against clotting is its prevention of spike protein interaction with CD-147 on human red blood cells, preventing spike proteins from docking there, and by this means preventing the clumping of red blood cells together. [12]
Ivermectin not only binds to part of the spike protein, but, in a trifecta of good fortune for the human sufferer of spike protein injury, it binds to all three spike protein subunits, both the structural S2 subunit, as well as both of the two S1 subunits. [13] This comprehensive binding effect makes ivermectin’s thwarting of spike mischief that much more effective, than if binding spike only at a single molecule.
COVID-vaccinated people tend to have high levels of inflammation and low immune function, suffering notoriously frequent bouts of COVID, despite the high-profile advertising of the vaccine that they received. Seneff, Nigh et al found that this immune damage was primarily characterized by loss of Type I Interferon, our most important immune chemical signaling agent. [14] Ivermectin helps restore Type I interferon and interferon-related genes. [15] Also, because ivermectin so thoroughly binds spike proteins, at multiple sites, it holds promise for the related vaccine escape strains, Delta, Omicron, etc. that have continually plagued COVID-vaccinated individuals.
I personally have found in my medical practice that COVID-vaccinated patients tend to feel much better very quickly after taking even one ivermectin dose, and they seem to do much better than those who refuse to take it. I have not yet seen such quick improvements in both wellbeing and energy in the COVID-vaccinated with any other treatment so far as after even one dose of ivermectin.
Ivermectin can be taken daily or weekly. It has been taken on a weekly basis for decades by people in tropical areas. The safety profile is very impressive. Because ivermectin has been established as one of the world’s safest drugs, [16] the first clinical trial phases have already been completed. As a re-purposed drug, it can reduce the time frame for widespread use and benefit. [17] 12 mg / day has been observed to be a generally well-tolerated dose for adults. Ivermectin is absorbed 2.5 times better with food than without. 12 mg doses are available, [18] but consulting with your healthcare provider is essential to best address individual needs, for which this article is no adequate substitute.
Protecting the brain
There are at least three known ways that COVID vaccines can injure the brain in unfortunate circumstances.[19] Let’s consider the most promising ways to reverse as much as possible such injuries.
Agmatine
Agmatine is made in the body from arginine, a common amino acid in most protein-rich foods. You likely eat some arginine at least once or twice per day, even if vegan. Chemically, agmatine is classified as a polyamine, which is like a protein or peptide, but much smaller.
Agmatine, when supplemented, has been shown to protect neurons [20] and the blood brain barrier. [21] [22] It also prevents oxidation and edema.[23] It has shown a lot of promise against chronic diseases of the brain, such as Parkinson’s and Alzheimer’s, [24] as well as acute attack, such as stroke. [25]
Some of the specific effects are that Agmatine increases blood flow into and out of the nervous system, seems to improve cognitive function and helps to repair brain injury. [26] [27]
Dosing 500 mg, once or twice per day seems to be well-tolerated, and much smaller than the 2670 mg /day taken orally for five years in one study, [28] but must be discussed with your healthcare provider, for best individual care.
Phosphatidyl serine
Phosphatidyl serine (PS) is a naturally occurring molecule in the body, located in the membranes of human cells. It serves to keep cells responsive to signaling with other cells. It has been said that PS is the best defense against age-related cognitive decline.
In mice, PS was shown to improve learning and memory as well as myelination within three months, [29] and in rats in three weeks, [30] and that was after the rats had initially been given a neurotoxin. Another rat study showed that brain inflammation, neurological deficits and that surgically-induced ischemic (stroke-like) injury was improved within 24 to 72 hours with PS. [31] Another study found that inflammation was reduced and viable neurons increased, including in the hippocampus, which is active in learning and memory, following oral dosing of PS. [32]
I have used phosphatidyl serine when indicated with my patients for many years, and have found it to be helpful and well-tolerated at 100 mg oral dosing in the evenings. Some doctors dose it more frequently throughout the day. This is another substance that should be discussed with a local healthcare provider before starting. For example, I would generally not give PS to an Addison’s Disease patient, due to an observed cortisol-lowering effect.
Protecting the heart and blood vessels
Nattokinase
Nattokinase is an exciting and promising intervention for those with spike protein exposure. Nattokinase is an enzyme from a traditional Japanese fermented food, natto, which is made from soy. Tanikawa et al found that nattokinase degrades the spike protein, in a dose-dependent and time-dependent manner. [33]
Nattokinase also has the highest fibrinolytic and thrombolytic (clot-breaking) effect of tested substances by oral route, and very importantly, it does this without provoking bleeding as a side effect. [34] Many studies have been published on the clot-dissolving effect of nattokinase. [35] Chemically induced clots in dogs were dissolved, and imaging showed that normal blood flow was restored, within five hours after oral dosing of nattokinase. [36] Human response to a single dose of 2000 units of nattokinase showed similar clot-dissolving effect within 4 hours. [37]
These effects seem especially well-suited to COVID vaccine blood vessel injuries, because it is the walls of the blood vessels that are damaged with disruption to normal blood flow that has been so dangerous for COVID-vaccinated people. [38] [39] Those vessel walls and the clots that form at their inner surface seem to be repaired by nattokinase. [40]
I have asked my covid-vaccinated patients to take nattokinase 2000 units per day, a typically well-tolerated dose, [41] while running these labs every 3 months: D-dimer, CBC / platelets, fibrinogen, PT / INR, if any of those have been out of reference range. Naturopathic physicians have recommended nattokinase and similar for decades for some of our cardiovascular patients, when indicated, and I have never known it to cause new problems. It seems to be generally well-tolerated.
Protecting the immune system
Vitamin D
Vitamin D3, also named cholecalciferol, is the active form of vitamin D. The irony of vitamin D3 luxurious wealth in the homeless (but without other reasons for the rest of us to envy such an economic condition) is that their long exposure to sunlight begins vitamin D production in the skin and is further developed in the liver and kidneys, and this natural production is widely considered to be the best quality vitamin D. Supplemented vitamin D3, while often lifesaving, is a less desirable substitute for skin exposure to sunlight, and of course, must be without sunscreen. Sunscreen, besides containing carcinogenic and endocrine-disrupting ingredients, interferes with optimal vitamin D production. I have lived for decades in one of the sunniest places on earth, Arizona, and play outdoor sports. I have never used sunscreen, because of – not in spite of – risk / benefit analysis.
Vitamin D3 does not seem to affect spike protein antibodies, and may not have much interaction directly with spike proteins,[42] but indirectly, it impacts the ACE-2 receptors that spike proteins use for entry to human cells. [43] [44] The range of benefits for immune function imparted by vitamin D3 is vast, and seems to affect all major aspects of immune function. I cited 130 studies in the chapter on Vitamin D alone, for use against SARS-CoV-2 and COVID, in the book The Defeat Of COVID. [45] Of those immune effects that could benefit the COVID-vaccinated, I think one of the strongest may be its support of Type I interferon. Type I interferon is one of the most important chemical messengers in our immune systems, and this is one of the huge losses of the COVID-vaccinated. This loss of Type I interferon is likely the main reason why they suffer repeated bouts of COVID. [46] If vitamin D3 levels are above 50, (and I prefer them to be 70 to 100), then both acute COVID and long COVID have been far less likely to cause hospitalization and death. 109 treatment studies from 32 countries show overwhelming benefit of vitamin D against COVID disease and SARS-CoV-2. [47]
Another protection of vitamin D against COVID-vaccine injury likely involves the following. Researchers have found that vitamin D stabilizes the endothelium within 24 hours, by strengthening cell-cell junctions. [48] The endothelium that lines all of our blood vessels is where tremendous damage is seen in the recent epidemic of myocarditis and brain injuries following the COVID vaccines.
At my clinic, for a variety of reasons, we almost all take 10,000 to 14,000 units of vitamin D3 per day, patients and staff, even those of us who have 20+ minutes average sunlight exposure per day. However, you and your healthcare provider may prefer different dosing. Due to the highest quality vitamin D availability from sun exposure, it may be helpful for the COVID-vaccinated, and probably everyone else as well, to incorporate outdoor time on a daily basis.
None of these substances can be assumed to be ‘good enough.’
Because none of the above substances can be expected to completely antidote the mild to moderately poisonous effects of the COVID vaccines, I hereby do NOT endorse those vaccines for use by anyone of any age group. Nobody should read this article, and then say, ‘Well, okay, I’ll give in to my employer / parent / sibling, etc. and get the jab, just to keep the peace, because I can always antidote it later.’ No you cannot always, and can never fully, antidote it.
Rather than relying on an elusive holy grail antidote, you must fight with every legal means available to you to keep these experimental substances out of your body. If you have already had one or a few doses, you must fight like hell, fight as hard as the unvaccinated, to not be inflicted with any more. In this blunt language, I hope to convey necessary urgency.
Religious exemptions are strong, even indisputable, arguments, when well-expressed, throughout the United States. I offer some thoughts related to defense of a religious exemption. [49] [50] Such arguments are also available to people of no recognized religion, and they must be equally available and accessible, on the basis of the Equal Protections Clause of the 14th Amendment to the US Constitution and the 1964 Civil Rights Act.
There are also legal arguments for refusing mandated medical procedures on the assertion of bodily autonomy, based on a century of case law, including many Supreme Court cases. [51]
There are also medical exemptions from principled and courageous medical practitioners near you. If you can’t find any, contact my office in Tempe, Arizona, and we will try to help.
Dr. Colleen Huber, author of The Defeat Of COVID and Neither Safe Nor Effective: The Evidence Against the COVID Vaccines.
[1] F Yap. FLCCC I-Recover protocol: post vaccine treatment protocol. Mar 18 2023. https://covid19.onedaymd.com/2022/05/treatment-for-post-vaccine-syndrome-i.html
[2] C Huber. Neither Safe Nor Effective: The Evidence Against the COVID Vaccines. May 2022. https://www.amazon.com/Neither-Safe-Nor-Effective-Evidence/dp/B0B1C1F5HB/ref=sr_1_1
[3] B Kumar, M Jeyaraman, et al. A wonder drug in the arsenal against COVID-19: Medication evidence from ivermectin. Jun 2020. Journal of advances in Medicine and Medical Research. https://www.researchgate.net/profile/Madhan-Jeyaraman/publication/342734823
[4] L Kircik, J Del Rosso, et al. Over 25 years of clinical experience with ivermectin: An overview of safety for an increasing number of indications. Mar 2016. 15 (3). 325-332. https://pubmed.ncbi.nlm.nih.gov/26954318/
[5] K Wagstaff, H Sivakumaran, et al. Ivermectin is a specific inhibitor of importin alpha / beta-mediated nuclear import able to inhibit replication of HIV-1 virus and dengue virus. May 1 2012. J Biochem. 443 (3). 851-856. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327999/
[6] S Yang, C Atkinson, et al. The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha / beta 1 heterodimer. May 2020. Antiviral Res. https://pubmed.ncbi.nlm.nih.gov/32135219/
[7] L Caly, J Druce, et al. The FDA-approved drug ivermectin inhibits the replications of SARS-CoV-2. Jun 2020. Antiviral Res. 178. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/
[8] C19early. Ivermectin for COVID-19. Apr 2023. C19ivm.org.
https://c19ivm.org/
[9] C Boschi, D, Scheim, et al. SARS-CoV-2 spike protein induces hemagglutination: Implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects. Dec 2022. Int J Mol Sci 23 (24) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779393/
[10] A Zaidi, P Dehgani-Mobaraki. The mechanisms of action of ivermectin against SARS-CoV-2 – an extensive review. 2022. J Antibiot. 75 (2). 60-71. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688140/#CR44
[11] A Eweas, A Alhossary, et al. Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2. 2020. Front Microbiol. 11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976659/
[12] T Behl, I Kaur, et al. CD-147 spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Feb 20 2022. Sci Total Environ. 808. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634688/
[13] A Choudhury, N Das, et al. Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in-silico approach. Mar 25 2021. Future Vir. https://www.futuremedicine.com/doi/10.2217/fvl-2020-0342
[14] S Seneff, G Nigh et al. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes and micro-RNAs. Jun 2022. Food Chem Toxicol. 164. https://pubmed.ncbi.nlm.nih.gov/35436552/
[15] C Seth, C Mas, et al. Long-lasting WNT-TCF response blocking and epigenetic modifying activities of Withanolide F in human cancer cells. 2016. PLoS One. 11 (12). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156407/
[16] T Jabeen, M Khader, et al. A review on the antiparasitic drug ivermectin for various viral infections and possibilities of using it for novel severe acute respiratory syndrome coronavirus. 2: New hope to treat coronavirus disease – 2019. Jun 2020. Asian J Pharm Clin Res. https://www.researchgate.net/publication/343742900
[17] A Zaidi, P Dehgani-Mobaraki. The mechanisms of action of ivermectin against SARS-CoV-2 – an extensive review. 2022. J Antibiot. 75 (2). 60-71. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688140/#CR44
[18] https://dir.indiamart.com/search
[19] C Huber. Brain injuries after COVID vaccination. Apr 10 2023. The Defeat Of COVID; Substack.
[20] G Gilad, V Gilad. Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Dec 22 2000. Neuroscience Letters. 296 (2-3). 97-100. https://www.sciencedirect.com/science/article/abs/pii/S0304394000016256?via%3Dihub
[21] M Ninkovic, I Stevanovic, et al. The use of agmatine provides the new insight in an experimental model of multiple sclerosis. Aug 2015. Neurochem Res. 40 (8). 1719-1727. https://pubmed.ncbi.nlm.nih.gov/26141226/
[22] S Ahn, S Kim, et al. Effects of agmatine on blood-brain barrier stabilization assessed by permeability MRI in a rat model of transient cerebral ischemia. Feb 2015. AJNR Am J Neuroradiol. 36 (2). 283-288. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965667/
[23] J Kim, Y Lee, et al. Agmatine attenuates brain edema and apoptotic cell death after traumatic brain injury. Jul 2015. J Korean Med Sci. 30 (7). 943-952. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479950/
[24] W Xu, L Gao, et al. Neuroprotective role of agmatine in neurological diseases. Nov 2018 Curr Neurpharmacol. 16 (9). 1296-1305. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251039/
[25] J Kim, M Yenari, et al. Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Sep 2004. Exp Neurol. 189 (1). 122-130. https://pubmed.ncbi.nlm.nih.gov/15296842/
[26] K Proefrock. Traumatic brain injuries. Lecture, Mar 25 2023. Southwest Conference on Botanical Medicine.
[27] J Kim, Y Lee, et al. Agmatine attenuates brain edema and apoptotic cell death after traumatic brain injury. Jul 2015. J Korean Med Sci. 30 (7). 943-952. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479950/
[28] G Gilad, V Gilad. Long-term (5 years), high daily dosage of dietary agmatine – evidence of safety: a case report. J Med Food. Nov 2014. 17 (11). 1256-1259. https://pubmed.ncbi.nlm.nih.gov/25247837/
[29] B Liu, N Zhang, et al. Preparation, characterization, evaluation of neuroprotective effect, and related mechanisms of phosphatidylserine emulsion in 5- and 12- week old mice. Feb 16 2022. J Agric Food Chem. 70 (6). 1852-1864. https://pubmed.ncbi.nlm.nih.gov/35107277/
[30] M Ye, B Han, et al. Neuroprotective effect of bean phosphatidyl serine on TMT-induced memory deficits in a rat model. Jul 11 2020. Int J Mol Sci. 21 (14). 4901. https://pubmed.ncbi.nlm.nih.gov/32664537/
[31] L Huang, H Tang, et al. The activation of phosphatidylserine / CD 36 / TGF-beta 1 pathway prior to surgical brain injury attenuates neuroinflammation in rats. Aug 11 2020. Oxid Med Cell Longev. https://pubmed.ncbi.nlm.nih.gov/32849998/
[32] A Partoazar, Z Seyyedian, et al. Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus. Jun 2021. Psychopharmacology (Berl). 238 (6). 1531-1539. https://pubmed.ncbi.nlm.nih.gov/33569644/
[33] T Tanikawa, Y Kiba, et al. Degradative effect of nattokinase on spike protein of SARS-CoV-2. Sep 2022. Molecules. 27 (17). 5405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458005/
[34] Y Weng, J Yao, et al. Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease. Mar 2017. Int J Mol Sci. 18 (3). 523. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372539/
[35] H Chen, E McGowan, et al. Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases. 2018. Biomark Insights. 13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043915/#bibr10-1177271918785130
[36] H Sumi, H Hamada, et al. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. 1990. Acta Haematol. 84 (3). https://pubmed.ncbi.nlm.nih.gov/2123064/
[37] Y Kurosawa, S Nirengi, et al. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. 20015. Sci Rep. 5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479826/
[38] Y Lei, J Zhang, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Mar 31 2021. Circulation Res. 128 (9). https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318902
[39] C Huber. Heart fatigue from vaccines, as shown by fluid dynamics. Jan 16 2022. The Defeat of COVID; Substack.
[40] Y Suzuki, K Kondo, et al. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Jul 2003. Life Sci. 73 (10). 1289-1298. https://pubmed.ncbi.nlm.nih.gov/12850244/
[41] J Kim, S Gum, et al. Effects of nattokinase on blood pressure: a randomized, controlled trial. Aug 2008. Hypertens Res. Aug 2008. 31 (8). 1583-1588. https://pubmed.ncbi.nlm.nih.gov/18971533/
[42] R Fanne, M Moed, et al. SARS-CoV-2 infection-blocking immunity post natural infection: The role of vitamin D. Feb 2023. Vaccines (Basel). 11 (2). 475. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967845/
[43] C Cui, P Xu, et al. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of angiotensin system. Sep 2019. Science Direct. 26. https://www.sciencedirect.com/science/article/pii/S2213231719306949
[44] M Ortatatli, T Fatsa, et al. Potential role of vitamin D, ACE2 and the proteases as TMPRSS2 and furin on SARS-CoV-2 pathogenesis and COVID-19 severity. Feb 14 2023. Arch Med Res. https://www.sciencedirect.com/science/article/pii/S0188440923000152
[45] C Huber. The Defeat of COVID. Apr 10 2021. https://www.amazon.com/Defeat-COVID-medical-studies-doesnt/dp/0578248212
[46] S Seneff, G Nigh et al. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes and micro-RNAs. Jun 2022. Food Chem Toxicol. 164. https://pubmed.ncbi.nlm.nih.gov/35436552/
[47] C19early/d. Vitamin D for COVID-19. https://c19early.org/d
[48] C Gibson, C Davis, et al. Dietary vitamin D and its metabolites non-genomically stabilize the endothelium. 2015. PLoS One. 10 (10). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607301/
[49] C Huber. Religious Exemption, Inside Out. Jun 22 2022. The Defeat of COVID; Substack.
[50] C Huber. The US Constitution v Mandates. Mar 16 2023. The Defeat of COVID; Substack.
[51] C Huber. Bodily Autonomy – Judicial Precedent. May 3 2022. The Defeat of COVID; Substack.
Another keeper - well-written, to the point, persuasive, informative!
During the summer of '20, I read that 96% of those hospitalized with covid were vitamin D deficient. Sometime later I read that 96% of cancer victims are D deficient. I added it to my daily supplements in '20 (5,000 IU in the summer, 10,000 IU in the winter) and haven't been sick a day since.
Thank you for every word that you write.